Magnesium and Ammonium-Potassium Lithospermates B, the Active Principles Having a Uremia-Preventive Effect from Salvia miltiorrhiza

Takashi Tanaka, Satoshi Morimoto, Gen ichiro Nonaka, Itsuo Nishioka, Takako Yokozawa, C. Chung, Hikokichi Oura, Hae Young

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

The active components which exhibit the improving effect on uremic symptoms have been isolated from Salviae miltiorrhizae Radix and characterized as magnesium lithospermate (1) and ammonium-potassium lithospermate (2). The stereostructure of lithospermic acid, which had remained unclarified, was also determined on the basis of chemical and spectroscopic data.

Original languageEnglish
Pages (from-to)340-344
Number of pages5
JournalChemical and Pharmaceutical Bulletin
Volume37
Issue number2
DOIs
Publication statusPublished - Jan 1 1989

Fingerprint

Salvia miltiorrhiza
Uremia
Ammonium Compounds
Magnesium
Potassium
lithospermic acid
lithospermate B

All Science Journal Classification (ASJC) codes

  • Chemistry(all)
  • Drug Discovery

Cite this

Magnesium and Ammonium-Potassium Lithospermates B, the Active Principles Having a Uremia-Preventive Effect from Salvia miltiorrhiza. / Tanaka, Takashi; Morimoto, Satoshi; Nonaka, Gen ichiro; Nishioka, Itsuo; Yokozawa, Takako; Chung, C.; Oura, Hikokichi; Young, Hae.

In: Chemical and Pharmaceutical Bulletin, Vol. 37, No. 2, 01.01.1989, p. 340-344.

Research output: Contribution to journalArticle

Tanaka, Takashi ; Morimoto, Satoshi ; Nonaka, Gen ichiro ; Nishioka, Itsuo ; Yokozawa, Takako ; Chung, C. ; Oura, Hikokichi ; Young, Hae. / Magnesium and Ammonium-Potassium Lithospermates B, the Active Principles Having a Uremia-Preventive Effect from Salvia miltiorrhiza. In: Chemical and Pharmaceutical Bulletin. 1989 ; Vol. 37, No. 2. pp. 340-344.
@article{b76ab92b98ee4bdfb970b6c7f3fef181,
title = "Magnesium and Ammonium-Potassium Lithospermates B, the Active Principles Having a Uremia-Preventive Effect from Salvia miltiorrhiza",
abstract = "The active components which exhibit the improving effect on uremic symptoms have been isolated from Salviae miltiorrhizae Radix and characterized as magnesium lithospermate (1) and ammonium-potassium lithospermate (2). The stereostructure of lithospermic acid, which had remained unclarified, was also determined on the basis of chemical and spectroscopic data.",
author = "Takashi Tanaka and Satoshi Morimoto and Nonaka, {Gen ichiro} and Itsuo Nishioka and Takako Yokozawa and C. Chung and Hikokichi Oura and Hae Young",
year = "1989",
month = "1",
day = "1",
doi = "10.1248/cpb.37.340",
language = "English",
volume = "37",
pages = "340--344",
journal = "Chemical and Pharmaceutical Bulletin",
issn = "0009-2363",
publisher = "The Pharmaceutical Society of Japan",
number = "2",

}

TY - JOUR

T1 - Magnesium and Ammonium-Potassium Lithospermates B, the Active Principles Having a Uremia-Preventive Effect from Salvia miltiorrhiza

AU - Tanaka, Takashi

AU - Morimoto, Satoshi

AU - Nonaka, Gen ichiro

AU - Nishioka, Itsuo

AU - Yokozawa, Takako

AU - Chung, C.

AU - Oura, Hikokichi

AU - Young, Hae

PY - 1989/1/1

Y1 - 1989/1/1

N2 - The active components which exhibit the improving effect on uremic symptoms have been isolated from Salviae miltiorrhizae Radix and characterized as magnesium lithospermate (1) and ammonium-potassium lithospermate (2). The stereostructure of lithospermic acid, which had remained unclarified, was also determined on the basis of chemical and spectroscopic data.

AB - The active components which exhibit the improving effect on uremic symptoms have been isolated from Salviae miltiorrhizae Radix and characterized as magnesium lithospermate (1) and ammonium-potassium lithospermate (2). The stereostructure of lithospermic acid, which had remained unclarified, was also determined on the basis of chemical and spectroscopic data.

UR - http://www.scopus.com/inward/record.url?scp=0024539775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024539775&partnerID=8YFLogxK

U2 - 10.1248/cpb.37.340

DO - 10.1248/cpb.37.340

M3 - Article

VL - 37

SP - 340

EP - 344

JO - Chemical and Pharmaceutical Bulletin

JF - Chemical and Pharmaceutical Bulletin

SN - 0009-2363

IS - 2

ER -